Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem

European Journal of Pharmacology

Volumn 313, Issue 1-2, 1996, Pages 35-42

  Sanger, David J ^a   Morel, Eliane ^a   Perrault, Ghislaine ^a  

^a SANOFI   (France)

Author keywords

BZ ( ) receptor; Hypnotic; Zaleplon; Zolpidem

Indexed keywords

CHLORDIAZEPOXIDE; HYPNOTIC AGENT; ISONIAZID; PENTETRAZOLE; ZOLPIDEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG DISCRIMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TONIC SEIZURE;

EID: 0030579072     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00510-9     Document Type: Article

References (37)

1. Allen, D., H.V. Curran and M. Lader, 1993, The effects of single doses of CL 284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers, Eur. J. Clin. Pharmacol, 45, 313.
2. Arbilla, S., H. Depoortere, P. George and S.Z. Langer, 1985, Pharmacological profile of zolpidem at benzodiazepine receptors and electrocorticogram in rats, Naunyn-Schmiedeberg's Arch. Pharmacol. 330, 245.
3. Beer, B., J.R. Leni, W.H. Wu, D. Clody, P. Amorusi, J. Rose, T. Mant, J. Gaudreault, A. Cato and W. Stern, 1994, A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic, J. Clin. Pharmacol. 34, 335.
4. 1) subtype, J. Pharmacol. Exp. Ther. 245, 1033.
5. Cohen, C. and D.J. Sanger, 1994, Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps, Psychopharmacology 115, 86.
6. Cox, A., P. Boyland, J.P. Gent and M. Feely, 1988, An investigation of anti-convulsant tolerance to zolpidem in mice, Br. J. Pharmacol. 95, 667P.
7. Day, I.P., D.E. Clody, M.M. Monaghan, M.S. Abel, J.P. Ousza and B. Beer, 1992, Pharmacology of CL 284,846, a non-benzodiazepine sedative with reduced amnesic liability, Soc. Neurosci. Abstr. 18, 725.
8. Depoortere, H., B. Zivkovic, K.G. Lloyd, D.J. Sanger, G. Perrault, S.Z. Langer and G. Bartholini, 1986, Zolpidem, a novel non-benzodiazepine hypnotic. I. Neuropharmacological and behavioral effects, J. Pharmacol. Exp. Ther. 237, 649.
9. A receptor, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 246, 283.
10. File, S.E., 1985, Tolerance to the behavioral actions of benzodiazepines, Neurosci. Biobehav. Rev. 9, 113.
11. Garratt, J.C., J.P. Gent, M. Feely and J.R.M. Haigh, 1988, Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential?, Eur. J. Pharmacol. 145, 75.
12. Goa, K.L. and R.C. Heel, 1986, Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic, Drugs 32, 48.
13. Griebel, G., D.J. Sanger and G. Perrault, 1996, The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands, Psychopharmacology 124, 245.
14. 2Lsub-units stably transfected into mouse fibrobalst L-cells, Br. J. Pharmacol. 107, 732.
15. A receptors in acutely dissociated rat striatal and cerebellar neurons. Neuropharmacology 35, 137.
16. Lader, M., 1992, Rebound insomnia and newer hypnotics, Psychopharmacology 108, 248.
17. Langtry, H.D. and P. Benfield, 1990, Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential, Drugs 40, 291.
18. Löscher, W. and H.H. Frey, 1977, Effect of convulsant and anticonvulsant agents on level and metabolism of γ-aminobutyric acid in mouse brain, Naunyn-Schmiedeberg's Arch. Pharmacol. 296, 263.
19. Löscher, W., C. Rundfeldt and D. Honack, 1991, Tolerance to anticonvulsant effects of the partial benzodiazepine receptor agonist abecarnil in kindled rats involves learning, Eur. J. Pharmacol. 202, 303.
20. Mao, C.C., A. Guidotti and E. Costa, 1975, Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action of diazepam, Naunyn-Schmiedeberg's Arch. Pharmacol. 289, 369.
21. McElroy, J.F., R.L. Fleming and R.S. Feldman, 1985, Comparison between chlordiazepoxide and CL 218,872 - a synthetic non-benzodiazepine ligand for benzodiazepine receptors on spontaneous locomotor activity in rats, Psychopharmacology 85, 224.
22. Ozawa, M., K. Sugimachi, Y. Nakada-Kometani, T. Akai and M. Yamaguchi, 1994, Chronic pharmacological activities of the novel anxiolytic β-carboline abecarnil in rats, J. Pharmacol. Exp. Ther. 269, 457.
23. Perrault, G., E. Morel, D.J. Sanger and B. Zivkovic, 1990, Pharmacological profiles of four new hypnotics with different chemical structures: quazepam, brotizolam, zopiclone and zolpidem, Eur. J. Pharmacol. 187, 487.
24. Perrault, G., E. Morel, D.J. Sanger and B. Zivkovic, 1992, Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem, J. Pharmacol. Exp. Ther. 263, 298.
25. Perrault, G., E. Morel, D.J. Sanger and B. Zivkovic, 1993, Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence, Neuropharmacology 32, 855.
26. 5-subunit creates novel type II benzodiazepine receptor pharmacology, J. Neurochem. 54, 1802.
27. Sanger, D.J., 1995, Behavioural effects of novel benzodiazepine (ω) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue, Behav. Pharmacol. 6, 116.
28. 3H]-flumazenil binding in different regions of the rat central nervous system, Psychopharmacology 111, 315.
29. Sanger, D.J. and B. Zivkovic, 1986, The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic, Psychopharmacology 89, 317.
30. Sanger, D.J. and B. Zivkovic, 1987, Investigation of the development of tolerance to the actions of zolpidem and midazolam, Neuropharmacology 26, 1513.
31. Sanger, D.J. and B. Zivkovic, 1988, Further behavioural evidence for the selective sedative action of zolpidem, Neuropharmacology 27, 1125.
32. A receptors, Neuropharmacology 31, 693.
33. Sanger, D.J., J. Benavides, G. Perrault, E. Morel, C. Cohen, D. Joly and B. Zivkovic, 1994, Recent developments in the behavioral pharmacology of benzodiazepine (w) receptors: evidence for the functional significance of receptor subtypes, Neurosci. Biobehav. Rev. 18, 355.
34. Vanover, K.E. and J.E. Barrett, 1994, Evaluation of the discriminative stimulus effects of the novel sedative hypnotic CL 284,846, Psychopharmacology 115, 289.
35. Von Voigtlander, P.F. and R.A. Lewis, 1991, A rapid screening method for the assessment of benzodiazepine receptor related physical dependence in mice, J. Pharmacol. Methods 26, 1.
36. Woods, J.H., J.L. Katz and G. Winger, 1992, Benzodiazepines: use, abuse and consequences, Pharmacol. Rev. 44, 151.
37. Zivkovic, B., G. Perrault, E. Morel and D.J. Sanger, 1988, Comparative pharmacology of zolpidem and other hypnotics and sleep inducers, in: Imidazopyridines in Sleep Disorders, eds. J.P. Sauvanet, S.Z. Langer and P.L. Morselli (Raven, New York) p. 97.